Data / Form D filings / Celtaxsys, Inc.
Celtaxsys, Inc.: Form D filings
Celtaxsys, Inc., a biotechnology company in Atlanta, GA, filed 3 Form D notices with the SEC between 2009 and 2015. The latest, on June 17, 2015, reports $21.6 million sold of a $40 million offering to 8 investors.
Find out what Celtaxsys, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 17th Street, Suite 530, Atlanta, GA, 30363
- Phone
- (470) 206-0153
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1334381
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2015 | New notice | $40,003,981 | $21,628,985 | $18,374,996 | 8 | Jun 3, 2015 | sec.gov |
| Oct 29, 2010 | New notice | $10,653,500 | $4,231,386 | $6,422,114 | 6 | Oct 25, 2010 | sec.gov |
| May 7, 2009 | New notice | $5,000,000 | $2,040,000 | $2,960,000 | 5 | May 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| H. Daniel Perez, M.D. | Director | |
| Maxim Daniel Gorbachev | Director | |
| Nicole P. Vitullo | Director | |
| Eric Daniel Springman | Executive Officer | |
| Sanjeev P. Ahuja, M.D. | Executive Officer | |
| Gerry Daniel Brunk | Director | |
| Greg Duncan | Executive Officer, Director | |
| William P. Reddick | Executive Officer | |
| Michael W. Masters | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Jun 15, 2015 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celtaxsys, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.